Bicocca Open Archive

Logo unimib boa
VILLA, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.601
AS - Asia 3.661
EU - Europa 3.300
SA - Sud America 565
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 15.194
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.421
SG - Singapore 1.224
IT - Italia 825
CN - Cina 743
HK - Hong Kong 739
RU - Federazione Russa 602
VN - Vietnam 501
BR - Brasile 461
DE - Germania 443
IE - Irlanda 344
SE - Svezia 333
UA - Ucraina 213
GB - Regno Unito 149
CA - Canada 131
ID - Indonesia 118
FI - Finlandia 90
AT - Austria 84
IN - India 69
AR - Argentina 51
FR - Francia 46
KR - Corea 44
DK - Danimarca 41
TR - Turchia 39
MX - Messico 35
BD - Bangladesh 32
NL - Olanda 31
ZA - Sudafrica 29
ES - Italia 26
JP - Giappone 24
IQ - Iraq 22
PL - Polonia 22
EC - Ecuador 19
BE - Belgio 17
IL - Israele 16
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
IR - Iran 11
MA - Marocco 9
PK - Pakistan 9
PY - Paraguay 9
UZ - Uzbekistan 9
CL - Cile 7
VE - Venezuela 6
AZ - Azerbaigian 5
EU - Europa 5
TN - Tunisia 5
TW - Taiwan 5
BG - Bulgaria 4
KE - Kenya 4
PE - Perù 4
RO - Romania 4
CO - Colombia 3
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
LB - Libano 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DM - Dominica 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
KZ - Kazakistan 2
MU - Mauritius 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.194
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.457
Singapore 743
Hong Kong 735
Fairfield 663
Ashburn 593
Woodbridge 518
Houston 378
Wilmington 351
Dublin 333
Frankfurt am Main 320
Milan 312
Chandler 269
Seattle 241
Cambridge 213
New York 198
Jacksonville 180
Santa Clara 174
Ho Chi Minh City 151
Princeton 148
Dallas 141
Beijing 119
Los Angeles 119
Hefei 114
Hanoi 112
Jakarta 111
Dearborn 98
Altamura 89
Lawrence 69
Nanjing 68
Moscow 64
Vienna 63
Buffalo 56
Chicago 56
The Dalles 52
Ottawa 47
São Paulo 47
Guangzhou 46
San Diego 43
Seoul 41
Helsinki 29
Lachine 29
Fremont 28
Council Bluffs 26
Dong Ket 26
Lappeenranta 26
Grafing 24
Shanghai 23
Brooklyn 20
Tokyo 20
Andover 19
Rio de Janeiro 19
Montreal 18
Salt Lake City 18
Shenyang 18
Toronto 18
Nanchang 17
Johannesburg 16
Munich 16
Rome 16
Warsaw 16
Biên Hòa 15
Haiphong 15
London 15
Boardman 14
Brussels 14
Hebei 14
Stockholm 14
Thái Nguyên 14
Da Nang 13
Kent 13
Phoenix 13
Denver 12
Mexico City 12
Norwalk 12
Atlanta 11
Orem 11
Dhaka 10
Ha Long 10
Jiaxing 10
Monza 10
Nuremberg 10
Poplar 10
Brasília 9
Chennai 9
Curitiba 9
Hải Dương 9
Kocaeli 9
Paris 9
Tampa 9
Carate Brianza 8
Detroit 8
Hyderabad 8
Miami 8
Naples 8
Ninh Bình 8
Porto Alegre 8
Santo André 8
Tashkent 8
Tianjin 8
Ankara 7
Totale 10.396
Salva come PNG Salva come JPEG
Nome #
CHRNA2 and nocturnal frontal lobe epilepsy: Identification and characterization of a novel loss of function mutation 487
Analysis of human papillomavirus (HPV) 16 variants associated with cervical infection in Italian women 401
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 384
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 329
Molecular and imaging biomarkers in Alzheimer’s disease: A focus on recent insights 302
Variants in CHRNB2 and CHRNA4 identified in patients with insular epilepsy 299
Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing 294
Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE) 292
Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update 291
Long Non-Coding RNAs and Related Molecular Pathways in the Pathogenesis of Epilepsy 290
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges 286
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 280
Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics 273
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 265
Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease 257
The synergistic relationship between Alzheimer's disease and sleep disorders: An update 248
Genetic architecture and molecular, imaging and prodromic markers in dementia with lewy bodies: State of the art, opportunities and challenges 244
Potassium channels and human epileptic phenotypes: An updated overview 238
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 237
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms 215
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation 194
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis 193
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 185
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 185
Circulating miRNAs as potential biomarkers in Alzheimer’s disease 184
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 183
From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder 182
Epigenetics in Alzheimer’s Disease: A Critical Overview 178
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease 178
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis 174
GSK3β genetic variability in patients with Multiple Sclerosis 174
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 173
C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia 171
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder 165
Ehlers-Danlos Syndrome classical type: A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype 165
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 164
Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson’s disease: Molecular mechanisms connecting neuroinflammation to α-synuclein spreading pathology 162
A novel role of cardiac inwardly rectifying potassium channels explaining autonomic cardiovascular dysfunctions in a cuprizone-induced mouse model of multiple sclerosis 161
Immunoreactivity of muscarinic acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and kir channels in a model of epilepsy 161
Exome Sequencing in an ADSHE Family: VUS Identification and Limits 160
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder 160
Candidate gene analysis of selectin cluster in patients with multiple sclerosis 160
Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia 159
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 157
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration 151
TIMP1 Overexpression in Ovarian Cancer Spheroids: Implications for Prognosis, Resistance, and Metastatic Potential 149
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 146
FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration 143
Epileptic seizures in autosomal dominant forms of Alzheimer's disease 142
Homology Modelling, Molecular Docking and Molecular Dynamics Simulation Studies of CALMH1 against Secondary Metabolites of Bauhinia variegata to Treat Alzheimer’s Disease 141
Causal Frontotemporal Lobar Degeneration mutations: a novel MAPT mutation associated with the clinical phenotype of Progressive nonfluent Aphasia 140
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders 139
Unraveling the role of inwardly rectifying potassium channels in the hippocampus of an Aβ(1-42)-infused rat model of Alzheimer's disease 139
Edaravone: A Novel Possible Drug for Cancer Treatment? 138
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases 138
Ehlers-Danlos syndromes and epilepsy: An updated review 136
Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with alzheimer's disease 136
Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis 135
Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments 131
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects 131
Investigating cardiac morphological alterations in a pentylenetetrazol-kindling model of epilepsy 130
Psychosis in Parkinson’s Disease: A Lesson from Genetics 129
C9ORF72 repeat expansion is not detected in patients with multiple sclerosis 127
Genetics and expression analysis of Sp4 transcription factor in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 127
Circulating miRNAs as potential biomarkers in Alzheimer's disease 127
Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration? 127
GRN variability contributes to sporadic frontotemporal lobar degeneration 126
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration 122
Insights into Dysregulated Neurological Biomarkers in Cancer 120
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease 119
The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype 119
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 119
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration 117
Novel exon 1 progranulin gene variant in Alzheimer's disease 116
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 112
Tlr-mediated signal transduction and neurodegenerative disorders 111
Arylsulfatase a (Asa) in parkinson’s disease: From pathogenesis to biomarker potential 108
New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders 105
A 45-year-old Italian male with p.(Gly1815Ser) FBN1 mutation causing a mild variant of Marfan syndrome: A case study 105
Biomarkers for alzheimer’s disease: Where do we stand and where are we going? 105
MCP-1 A-2518G polymorphism: Effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels 104
Causal frontotemporal lobar degeneration mutations: a novel mutation in MAPT associated with non-fluent progressive aphasia phenotype 102
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 100
Transcription factor Sp1 is regulated by hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 98
Blood-based biomarkers in mild behavioral impairment: an updated overview 95
CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration 95
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration 91
Multi-omics for the understanding of brain diseases 86
Microfluidic platforms to unravel mysteries of alzheimer’s disease: How far have we come? 84
Expression and genetic analysis of microRNAs involved in multiple sclerosis 78
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 76
Ocular vascular changes: Choroidal thickness as an early biomarker for Alzheimer’s disease? 74
Totale 15.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.667
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.212 0 0 0 0 0 194 148 188 146 191 152 193
2021/20221.208 148 150 160 100 82 135 60 55 45 40 77 156
2022/20231.497 188 436 149 93 89 244 15 78 111 26 44 24
2023/20241.146 44 41 35 111 123 273 179 34 137 18 20 131
2024/20253.035 165 379 184 143 260 134 103 109 424 453 205 476
2025/20263.657 789 607 519 793 858 91 0 0 0 0 0 0
Totale 15.729